loxiglumide and l 365260
loxiglumide has been researched along with l 365260 in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Kimura, I; Kimura, M; Wakasono, S | 1 |
Blackmore, M; Doherty, E; Hirst, BH; Manning, JE | 1 |
Capellà, G; Clavé, P; Farré, R; González, AA; Monés, J | 1 |
Other Studies
3 other study(ies) available for loxiglumide and l 365260
Article | Year |
---|---|
Loxiglumide, L-364,718 and L-365,260 prevent the inhibition of spontaneous acetylcholine release from the frontal cerebral cortex of freely moving rat peripherally administered with cholecystokinin-8S.
Topics: Acetylcholine; Animals; Benzodiazepinones; Cerebral Cortex; Cholecystokinin; Devazepide; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Phenylurea Compounds; Proglumide; Rats; Rats, Wistar; Receptors, Cholecystokinin | 1995 |
Autocrine growth stimulation of human renal Wilms' tumour G401 cells by a gastrin-like peptide.
Topics: Benzamides; Benzodiazepinones; Cell Division; Devazepide; Gastrins; Humans; Indoles; Kidney Neoplasms; Meglumine; Phenylurea Compounds; Proglumide; Receptors, Cholecystokinin; Tumor Cells, Cultured; Wilms Tumor | 1994 |
Pharmacological and molecular characterization of muscular cholecystokinin receptors in the human lower oesophageal sphincter.
Topics: Adult; Aged; Benzodiazepines; Benzodiazepinones; Esophagogastric Junction; Female; Gastric Emptying; Gastrins; Gastrointestinal Agents; Gene Expression; Hormone Antagonists; Humans; In Vitro Techniques; Indoleacetic Acids; Male; Middle Aged; Phenylurea Compounds; Proglumide; Receptors, Cholecystokinin; Restriction Mapping; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sincalide; Thiazoles | 2000 |